An apparently effective countermeasure for doxorubicin extravasation.
D001639:Bicarbonates / Q000494:pharmacology*; D004317:Doxorubicin / Q000009:adverse effects* / Q000378:metabolism; D006801:Humans; D007279:Injections, Subcutaneous / Q000009:adverse effects*
D001639:Bicarbonates; D004317:Doxorubicin